123 related articles for article (PubMed ID: 37563785)
1. Comparison Between Radial and Femoral Artery Access for Transarterial Chemoembolisation in Patients With Hepatocellular Carcinoma.
Hedjoudje M; Barat M; Dohan A; Lucas A; Dautry R; Coriat R; Marchese U; Pol S; Parlati L; Soyer P
Can Assoc Radiol J; 2024 Feb; 75(1):178-186. PubMed ID: 37563785
[TBL] [Abstract][Full Text] [Related]
2. Transradial versus transfemoral access without closure device for transarterial chemoembolization in patients with hepatocellular carcinoma: a randomized trial.
Zhang X; Luo Y; Tsauo J; Zhao H; Gong T; Li J; Li Y; Zeng H; Sun W; Li X
Eur Radiol; 2022 Oct; 32(10):6812-6819. PubMed ID: 36018356
[TBL] [Abstract][Full Text] [Related]
3. Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients.
Du N; Ma J; Yang M; Zhang Z; Zheng Z; Zhang W; Yan Z
J Vis Exp; 2020 Sep; (163):. PubMed ID: 33016947
[TBL] [Abstract][Full Text] [Related]
4. Operator radiation dose during trans-hepatic arterial chemoembolization: different patients' positions via transradial or transfemoral access.
Jiang H; Chen Y; Liao H; Gu Y; Meng X; Dong W
Diagn Interv Radiol; 2022 Jul; 28(4):376-382. PubMed ID: 35950283
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of a circumferential clip-based vascular closure device in cirrhotic and coagulopathic patients with hepatocellular carcinoma after doxorubicin drug-eluting beads transarterial chemoembolization.
Prajapati HJ; Rafi S; Edalat F; Kooby DA; Kim HS
Cardiovasc Intervent Radiol; 2014 Jun; 37(3):664-70. PubMed ID: 23934114
[TBL] [Abstract][Full Text] [Related]
6. The safety and efficacy of balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma refractory to conventional transcatheter arterial chemoembolization.
Kim PH; Gwon DI; Kim JW; Chu HH; Kim JH
Eur Radiol; 2020 Oct; 30(10):5650-5662. PubMed ID: 32409860
[TBL] [Abstract][Full Text] [Related]
7. The incidence and outcome of major complication following conventional TAE/TACE for hepatocellular carcinoma.
Tu J; Jia Z; Ying X; Zhang D; Li S; Tian F; Jiang G
Medicine (Baltimore); 2016 Dec; 95(49):e5606. PubMed ID: 27930585
[TBL] [Abstract][Full Text] [Related]
8. Transarterial Chemoembolisation (TACE) with Degradable Starch Microspheres (DSM) and Anthracycline in Patients with Locally Extensive Hepatocellular Carcinoma (HCC): Safety and Efficacy.
Gross A; Albrecht T
Cardiovasc Intervent Radiol; 2020 Mar; 43(3):402-410. PubMed ID: 31705244
[TBL] [Abstract][Full Text] [Related]
9. Transarterial chemoembolisation for advanced hepatocellular carcinoma: results from a North American cancer centre.
Molinari M; Kachura JR; Dixon E; Rajan DK; Hayeems EB; Asch MR; Benjamin MS; Sherman M; Gallinger S; Burnett B; Feld R; Chen E; Greig PD; Grant DR; Knox JJ
Clin Oncol (R Coll Radiol); 2006 Nov; 18(9):684-92. PubMed ID: 17100154
[TBL] [Abstract][Full Text] [Related]
10. Transradial versus transfemoral approach for TACE: a retrospective study.
You K; Guo T; Sun D; Song H; Liu Z
BMC Gastroenterol; 2023 Jan; 23(1):11. PubMed ID: 36631744
[TBL] [Abstract][Full Text] [Related]
11. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.
Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY
Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418
[TBL] [Abstract][Full Text] [Related]
12. Application of side-hole catheter technique for transradial arterial chemoembolization in patients with hepatocellular carcinoma.
Meng XX; Liao HQ; Liu HC; Jiang HL; Gu YF; Li X; Dong WH
Abdom Radiol (NY); 2019 Sep; 44(9):3195-3199. PubMed ID: 31144089
[TBL] [Abstract][Full Text] [Related]
13. Transradial approach for transcatheter arterial chemoembolization in patients with hepatocellular carcinoma: comparison with conventional transfemoral approach.
Shiozawa S; Tsuchiya A; Endo S; Kato H; Katsube T; Kumazawa K; Naritaka Y; Ogawa K
J Clin Gastroenterol; 2003; 37(5):412-7. PubMed ID: 14564191
[TBL] [Abstract][Full Text] [Related]
14. The Munich-Transarterial Chemoembolisation Score Holds Superior Prognostic Capacities Compared to TACE-Tailored Modifications of 9 Established Staging Systems for Hepatocellular Carcinoma.
Op den Winkel M; Nagel D; Op den Winkel P; Paprottka PM; Schmidt L; Bourhis H; Trojan J; Goeller M; Reiter FP; Stecher SS; De Toni EN; Gerbes AL; Kolligs FT
Digestion; 2019; 100(1):15-26. PubMed ID: 30282074
[TBL] [Abstract][Full Text] [Related]
15. Balloon-occluded transarterial chemoembolization using a 1.8-French tip coaxial microballoon catheter for hepatocellular carcinoma: technical and safety considerations.
Matsumoto T; Endo J; Hashida K; Ichikawa H; Kojima S; Takashimizu S; Watanabe N; Yamagami T; Hasebe T
Minim Invasive Ther Allied Technol; 2015 Apr; 24(2):94-100. PubMed ID: 25263680
[TBL] [Abstract][Full Text] [Related]
16. Imaging Changes and Clinical Complications After Drug-Eluting Bead Versus Conventional Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Multicenter Study.
Zhang L; Sun JH; Ji JS; Zhong BY; Zhou GH; Song JJ; Hou ZH; Huang P; Zhang S; Li Z; Zhu XL; Ni CF
AJR Am J Roentgenol; 2021 Oct; 217(4):933-943. PubMed ID: 33245680
[No Abstract] [Full Text] [Related]
17. Transradial arterial chemoembolization reduces complications and costs in patients with hepatocellular carcinoma.
Wu T; Sun R; Huang Y; Wang Z; Yin X; Zhu Z; Zhao Z; He J
Indian J Cancer; 2015 Dec; 52 Suppl 2():e107-11. PubMed ID: 26728666
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy of transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) for small hepatocellular carcinoma: comparison with TACE or RFA monotherapy.
Kim W; Cho SK; Shin SW; Hyun D; Lee MW; Rhim H
Abdom Radiol (NY); 2019 Jun; 44(6):2283-2292. PubMed ID: 30806742
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Survival Factors of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
Rohan T; Uher M; Matkulčík P; Zavadil J; Ostřížková L; Kiss I; Andrašina T; Válek V
Klin Onkol; 2020; 33(3):214-219. PubMed ID: 32683878
[TBL] [Abstract][Full Text] [Related]
20. Risk of acute kidney injury after transarterial chemoembolisation in hepatocellular carcinoma patients: A nationwide population-based cohort study.
Lee BC; Liu KL; Lin CL; Kao CH
Eur Radiol; 2017 Nov; 27(11):4482-4489. PubMed ID: 28593432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
